Esophagogastric Cancer Completed Phase 1 Trials for Carboplatin (DB00958)

IndicationStatusPhase
DBCOND0047780 (Esophagogastric Cancer)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01803282Study to Evaluate the Safety and Tolerability of Andecaliximab as Monotherapy and in Combination With Chemotherapy in Participants With Advanced Solid TumorsTreatment